Oct 9 (Reuters) - The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus sores in ...
The FDA has approved pritelivir (Hovilpri) tablets for adults with weakened immune systems who have mucocutaneous lesions ...
(Corrects sourcing in bullet 3, updates share reaction in bullet point 5) Oct 9 (Reuters) - Teva said on Friday it had ...
The FDA has approved pritelivir to treat mucocutaneous lesions caused by herpes simplex virus in immunocompromised adult ...
On Sept. 30, 2026, the FDA withdrew the accelerated approval of Zepzelca (lurbinectedin) for adults with metastatic small ...
The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...
Teva stock is a "Hold" as its "Pivot to Growth" strategy shows early promise but requires further execution. Click for more ...
Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective ...
The FDA approved the medication more than six months ahead of schedule after trials showed it nearly doubled median survival ...
The US Food and Drug Administration (FDA) is poised to make a comeback from the relatively low number of new drugs approved in 2016, though it's unlikely to match the approval highs from 2014 and 2015 ...
Teva Pharmaceutical Industries (NYSE:TEVA) said the U.S. Food and Drug Administration has approved WELTRUZA, a once-monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results